MIR497HG and breast carcinoma: In our study, MIR497HG was observed to be negatively correlated with tumor size, lymphocyte metastasis, and TNM staging in breast cancer patients via Chi-square test, and downregulated expression of MIR497HG was evaluated by RT-qPCR.